Saturday 17 October 2026
Export QHCQQ’s income statement to Excel — free account
Quorum Health Corporation
Follow QHCQQ
| Mar '20 | Dec '19 | Sep '19 | Jun '19 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.01 | 0.02 | 0.02 | 0.02 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1.57) | (0.52) | 1.45 | (3.95) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.80 | 0.74 | 0.67 | 0.69 | |
EV/EBITDA |
0.00 | 43.05 | 28.06 | 19.72 | |
EV/Operating CF |
(25.47) | (38.27) | 61.27 | 55.39 | |
EV/FCF |
(12.68) | (15.63) | (49.75) | (58.95) | |
Quick Ratio |
0.19 | 0.19 | 0.89 | 0.84 | |
Current Ratio |
0.26 | 0.26 | 1.21 | 1.43 | |
Net Debt/EBITDA |
(35.63) | 76.64 | (42.74) | 38.17 | |
Debt/Assets |
86.28% | 82.61% | 78.66% | 77.30% | |
Debt/Equity |
(4.08) | (5.22) | (5.89) | (9.34) | |
Asset Turnover |
1.01 | 1.10 | 1.13 | 1.12 | |
Operating CF/Net income |
0.11 | 1.73 | (0.33) | 0.62 | |
Capex/Depreciation |
(0.98) | (1.22) | (0.64) | (0.84) | |
Interest Coverage |
(1.48) | 0.08 | (1.27) | 0.51 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
51.27% | 47.85% | 51.31% | 48.26% | |
Intangible Assets out of Total Assets |
0.30 | 0.30 | 0.29 | 0.28 | |
Share Based Compensation of Revenue |
0.31% | 0.16% | 0.42% | 0.27% | |
Graham Net Nets |
(100.37) | (45.86) | (34.98) | (30.06) | |
Graham Number |
39.55 | 31.12 | 27.86 | 20.81 | |
Earnings Yield |
(1,560.00%) | (533.33%) | (423.14%) | (324.82%) | |
Free Cash Flow Yield |
(727.01%) | (279.95%) | (65.46%) | (51.63%) | |
Revenue per Share |
11.27 | 12.84 | 13.91 | 14.74 | |
Operating CF per Share |
(0.29) | (1.86) | 0.83 | (0.35) | |
Capex per Share |
(0.39) | (0.55) | (0.32) | (0.40) | |
Free Cash Flow per Share |
(0.68) | (2.41) | 0.52 | (0.75) | |
Cash per Share |
1.03 | 0.11 | 1.47 | 0.08 | |
Shareholders Equity per Share |
(10.31) | (7.88) | (6.74) | (4.33) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(10.31) | (7.88) | (6.74) | (4.33) | |
Free Cash Flow |
(20.73) | (72.15) | 15.59 | (22.54) | |
Working Capital |
(1,203.42) | (1,141.75) | 77.36 | 138.14 | |
Capital Expenditures |
(11.99) | (16.44) | (9.56) | (12.14) | |
Net Current Asset Value |
(1,378.21) | (1,318.84) | (1,277.17) | (1,235.68) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 726.48 | |
Capex to Sales |
0.03 | 0.04 | 0.02 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 23.87 | |
| Other line items | |||||
Average Receivables |
298.73 | 304.75 | 300.99 | 299.20 | |
Average Payables |
155.18 | 150.29 | 150.02 | 147.67 | |
Average Inventory |
41.23 | 42.20 | 43.14 | 44.11 | |
Average Assets |
1,567.35 | 1,532.99 | 1,567.45 | 1,616.40 | |
Average Common Equity |
(214.33) | (155.46) | (131.83) | (69.20) |
Columns are period end dates